FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999462612> ?p ?o ?g. }

• W2999462612 endingPage "1397" @default.
• W2999462612 startingPage "1389" @default.
• W2999462612 abstract "PURPOSE A powerful consequence of detecting cancer-associated pathogenic variants is the ability to test at-risk relatives (ARRs), termed cascade testing. However, historical studies suggest cascade testing uptake of 30% or less. Here, we tested the feasibility of a novel, streamlined method of cascade testing using telephone genetic counseling and mailed saliva-based genetic testing. PATIENTS AND METHODS Probands with newly diagnosed cancer-associated pathogenic variants were offered facilitated cascade testing whereby the genetics team identified and contacted ARRs by telephone to disclose the familial pathogenic variant and offer telephone counseling and mailed saliva testing. Results and guideline-based recommendations were reviewed by telephone and shared with the primary care physician. RESULTS Thirty probands were enrolled, and 114 ARRs were identified. Twelve ARRs were excluded (lived outside of the United States, n = 5; proband did not approve of contact, n = 7). Among 102 ARRs telephoned, contact was established with 95 (93%). Among 114 identified ARRs, 66 (58%) completed genetic testing. Among those completing testing, 27 (41%) carried the familial pathogenic variant. Surveys of ARRs at the time of genetic testing and 6 months later demonstrated low levels of anxiety, depression, distress, and uncertainty and high levels of satisfaction with testing. At 6 months, 7 ARRs with pathogenic variants had undergone cancer surveillance interventions and 4 had undergone cancer risk-reducing surgery. CONCLUSION Facilitated cascade testing with telephone genetic counseling and mailed saliva kits resulted in high testing uptake among ARRs. Positive genetic testing resulted in utilization of genetically targeted primary disease prevention at short-term follow-up. Facilitated cascade testing is a straightforward, low-cost, easily implemented strategy with significant potential to promote early detection for affected ARRs and reduce cancer mortality and should be evaluated in larger scale clinical trials." @default.
• W2999462612 created "2020-01-23" @default.
• W2999462612 creator A5001757617 @default.
• W2999462612 creator A5007178392 @default.
• W2999462612 creator A5024592292 @default.
• W2999462612 creator A5027074067 @default.
• W2999462612 creator A5031409087 @default.
• W2999462612 creator A5040643638 @default.
• W2999462612 creator A5042502449 @default.
• W2999462612 creator A5057824077 @default.
• W2999462612 creator A5058574041 @default.
• W2999462612 creator A5062861120 @default.
• W2999462612 creator A5079745233 @default.
• W2999462612 creator A5081041480 @default.
• W2999462612 creator A5081926691 @default.
• W2999462612 creator A5086089361 @default.
• W2999462612 creator A5088642530 @default.
• W2999462612 date "2020-05-01" @default.
• W2999462612 modified "2023-10-02" @default.
• W2999462612 title "Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling" @default.
• W2999462612 cites W1821180588 @default.
• W2999462612 cites W1952716868 @default.
• W2999462612 cites W1983777759 @default.
• W2999462612 cites W2015545341 @default.
• W2999462612 cites W2017523852 @default.
• W2999462612 cites W2036959864 @default.
• W2999462612 cites W2044531248 @default.
• W2999462612 cites W2050649647 @default.
• W2999462612 cites W2090074733 @default.
• W2999462612 cites W2099000973 @default.
• W2999462612 cites W2103528338 @default.
• W2999462612 cites W2111149927 @default.
• W2999462612 cites W2114792070 @default.
• W2999462612 cites W2118306494 @default.
• W2999462612 cites W2127670434 @default.
• W2999462612 cites W2166281097 @default.
• W2999462612 cites W2227524730 @default.
• W2999462612 cites W2295265451 @default.
• W2999462612 cites W2533690438 @default.
• W2999462612 cites W2605601673 @default.
• W2999462612 cites W2624605816 @default.
• W2999462612 cites W2745994405 @default.
• W2999462612 cites W2753565653 @default.
• W2999462612 cites W2755932276 @default.
• W2999462612 cites W2891920666 @default.
• W2999462612 cites W2999834615 @default.
• W2999462612 cites W4238445298 @default.
• W2999462612 doi "https://doi.org/10.1200/jco.19.02005" @default.
• W2999462612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7193751" @default.
• W2999462612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31922918" @default.
• W2999462612 hasPublicationYear "2020" @default.
• W2999462612 type Work @default.
• W2999462612 sameAs 2999462612 @default.
• W2999462612 citedByCount "44" @default.
• W2999462612 countsByYear W29994626122020 @default.
• W2999462612 countsByYear W29994626122021 @default.
• W2999462612 countsByYear W29994626122022 @default.
• W2999462612 countsByYear W29994626122023 @default.
• W2999462612 crossrefType "journal-article" @default.
• W2999462612 hasAuthorship W2999462612A5001757617 @default.
• W2999462612 hasAuthorship W2999462612A5007178392 @default.
• W2999462612 hasAuthorship W2999462612A5024592292 @default.
• W2999462612 hasAuthorship W2999462612A5027074067 @default.
• W2999462612 hasAuthorship W2999462612A5031409087 @default.
• W2999462612 hasAuthorship W2999462612A5040643638 @default.
• W2999462612 hasAuthorship W2999462612A5042502449 @default.
• W2999462612 hasAuthorship W2999462612A5057824077 @default.
• W2999462612 hasAuthorship W2999462612A5058574041 @default.
• W2999462612 hasAuthorship W2999462612A5062861120 @default.
• W2999462612 hasAuthorship W2999462612A5079745233 @default.
• W2999462612 hasAuthorship W2999462612A5081041480 @default.
• W2999462612 hasAuthorship W2999462612A5081926691 @default.
• W2999462612 hasAuthorship W2999462612A5086089361 @default.
• W2999462612 hasAuthorship W2999462612A5088642530 @default.
• W2999462612 hasBestOaLocation W29994626121 @default.
• W2999462612 hasConcept C104317684 @default.
• W2999462612 hasConcept C121608353 @default.
• W2999462612 hasConcept C126322002 @default.
• W2999462612 hasConcept C188997412 @default.
• W2999462612 hasConcept C2780673598 @default.
• W2999462612 hasConcept C501734568 @default.
• W2999462612 hasConcept C512399662 @default.
• W2999462612 hasConcept C54355233 @default.
• W2999462612 hasConcept C71924100 @default.
• W2999462612 hasConcept C80227256 @default.
• W2999462612 hasConcept C86803240 @default.
• W2999462612 hasConceptScore W2999462612C104317684 @default.
• W2999462612 hasConceptScore W2999462612C121608353 @default.
• W2999462612 hasConceptScore W2999462612C126322002 @default.
• W2999462612 hasConceptScore W2999462612C188997412 @default.
• W2999462612 hasConceptScore W2999462612C2780673598 @default.
• W2999462612 hasConceptScore W2999462612C501734568 @default.
• W2999462612 hasConceptScore W2999462612C512399662 @default.
• W2999462612 hasConceptScore W2999462612C54355233 @default.
• W2999462612 hasConceptScore W2999462612C71924100 @default.
• W2999462612 hasConceptScore W2999462612C80227256 @default.
• W2999462612 hasConceptScore W2999462612C86803240 @default.
• W2999462612 hasIssue "13" @default.

• next